Suchen
aTyr Pharma Ord Shs
LIFEZur Watchlist hinzufügen
20.420USD
+0.150+0.74%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
1.29BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über aTyr Pharma Ord Shs Unternehmen
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
aTyr Pharma Ord Shs Informationen
BörsenkürzelLIFE
Name des UnternehmensEthos Technologies Inc
IPO-datumMay 07, 2015
CEOColis (Peter George)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeMay 07
Addresse1606 Headway Circle
StadtAUSTIN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl78754
Telefon13026365400
Websitehttps://www.ethos.com/
BörsenkürzelLIFE
IPO-datumMay 07, 2015
CEOColis (Peter George)
Führungskräfte von aTyr Pharma Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Kunal Mehta
Mr. Kunal Mehta
Senior Vice President - Finance
Senior Vice President - Finance
128.16K
-19.88%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von aTyr Pharma Ord Shs?
Die fünf größten Anteilseigner von aTyr Pharma Ord Shs sind: Mr. Peter Colis
Wie viele Institutionen halten Anteile an aTyr Pharma Ord Shs (LIFE)?
Mit Stand vom 2026Q1 halten 258 Institutionen Anteile an aTyr Pharma Ord Shs, mit einem Gesamtmarktwert von etwa 61.21M, was 88.45% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -10216639.00 gestiegen.